Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast

CAR T-cell therapies have transformed the management of several previously incurable, treatment-refractory hematologic malignancies, including Multiple Myeloma (MM). With two CAR T-cell products now approved, and additional under investigation, the therapeutic landscape continues to evolve rapidly.In this educational podcast, Dr. Joseph Mikhael highlights key advances in CAR T-cell therapy for MM. He reviews the most impactful data published or presented in 2025 and offers expert insight into how these emerging findings may shape current and future treatment strategies.Launch/Release Date: December 17, 2025 Activity Expiration Date: November 30, 2026FACULTYJoseph Mikhael, MD, MEd, FRCPC, FACP, FASCOProfessor, Clinical Genomics and Therapeutics Translational Genomics Research Institute (TGen), City of Hope Cancer Center Chief Medical Officer International Myeloma FoundationThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.